More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus
Zahi Touma,Ioannis Parodis,Vibeke Strand
DOI: https://doi.org/10.3899/jrheum.2023-0947
2024-01-02
The Journal of Rheumatology
Abstract:Systemic lupus erythematosus (SLE) significantly affects different aspects of patients' health-related quality of life (HRQOL).1 In 1998, Outcome Measures in Rheumatology (OMERACT) proposed the first Core Domain Set (CDS) for SLE, which included disease activity, organ damage, adverse events, HRQOL, and economic costs.2 The SLE OMERACT working group (WG) was established in 2018 and includes 160 members representing over 25 countries in 5 continents. Currently the group is working on updating the CDS and will then proceed to evaluate the measurement properties of instruments specific for each domain to form the new OMERACT SLE Core Outcome Set.3 Both physician evaluation and patient perceptions of their health condition and well-being are important and complement each other for a holistic health assessment. Studies have shown a considerable discordance between physicians' and patients' assessments of health status and priorities. Whereas physician assessments of disease activity, damage, and adverse effects of therapies are based primarily on clinical and laboratory findings, patients' assessment of their health can be ascertained with the use of different patient-reported outcomes (PROs). PROs can offer insight into a spectrum of domains such as fatigue, depressive symptoms, pain, and physical function among others. Different generic and disease-specific HRQOL questionnaires have been developed and validated for patients with SLE.1,4 Commonly used generic questionnaires include the 36-item Short-Form Health Survey (SF-36),5 a legacy instrument, as well as the EuroQol 5-Dimensional questionnaire (EQ-5D), both commonly used questionnaires in SLE randomized controlled trials (RCTs)4,6 and observational studies.7 SLE-specific instruments have also been used, albeit less commonly, in SLE RCTs and research studies and include the Lupus Quality of Life (LupusQoL),8 SLE-specific Quality of Life Questionnaire (SLE-QOL),9 SLE Quality of Life Questionnaire (L-QoL),10 LupusPRO, and Lupus Impact Tracker.11 PROs can also ... Address correspondence to Dr. Z. Touma, Division of Rheumatology, Schroeder Arthritis Institute, Krembil Research Institute, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Lupus Program, EW 1-412, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. Email: Zahi.Touma{at}uhn.ca.
rheumatology